Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04992897 · ClinicalTrials.gov registry record
Real-world Data Analysis of REN Treatment in Migraine Patients
A clinical trial, sponsored by Theranica.
- Completed
- Registry status
- 12,151
- Enrollment target
NCT04992897: Completed study, sponsored by Theranica.
NCT04992897 is a clinical trial that has completed, run by Theranica. The registered enrollment target is 12,151 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04992897 has completed, sponsored by Theranica.
- COMPLETED
- Registry status
- 12,151 participants
- Enrollment target
Study Summary
Data analysis concerning four sets of metrics: A. Per-treatment patterns of REN use as a standalone treatment vs. in combination with medications. B. Per-user Intra-individual consistency of efficacy across multiple treatments (consistency defined as a response to treatment in at least 50% of treatments). C. Distribution of treatment intensity among users (the electroceutical equivalent to treatment dose). D. Prevalence and severity of adverse events.
Primary Outcome
Medication intake outcomes calculated based on the 2h post-treatment report and comprised of the percentage of treatments in which no rescue medications were used, treatments in which OTC medications were taken, treatments in which triptans were taken, treatments in which other prescription medications were taken, and treatments in which medication intake status was not reported. OTC included acetaminophen, NSAIDs, and combinations of the two, with or without caffeine.
Interventions
- DEVICE Remote Electrical Neuromodulation (REN)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,151 participants |
| Start Date | 2021-06-15 |
| Est. Completion | 2021-08-10 |
What the finished NCT04992897 record still lists
NCT04992897 is an observational study that tracks outcomes without assigning an intervention. Its 12,151 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Remote Electrical Neuromodulation (REN) is the first listed.
NCT04992897 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04992897 about?
NCT04992897 is a clinical study titled "Real-world Data Analysis of REN Treatment in Migraine Patients". Data analysis concerning four sets of metrics: A. Per-treatment patterns of REN use as a standalone treatment vs. in combination with medications. B. Per-user Intra-individual consistency of efficacy across multiple treatments (consistency defined as a response to treatment in at least 50% of treatm...
What is the current status of trial NCT04992897?
This trial is currently completed. The enrollment target is 12,151 participants. The study started on 2021-06-15. Estimated completion is 2021-08-10.
What interventions are being tested in trial NCT04992897?
The interventions under investigation include: Remote Electrical Neuromodulation (REN) (DEVICE).
Who is sponsoring clinical trial NCT04992897?
This trial is sponsored by Theranica, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
- NCT06273618 · 12,000 participants · NA
iLookOut Micro-learning to Improve Knowledge Retention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI